Covid-19: Cytokine storm and Coagulopathy biomarkers, IL-6 and D-Dimer, well managed with Nichi-Glucan REFIX in clinical study: https://www.medrxiv.org/content/10.1101/2021.08.09.21261738v1

Cell therapy solutions for corneal epithelial and endothelial diseases of GNCorp forge an alliance with Indian and African healthcare institutes
DMI group of institutes in India, Tanzania, Malawi and Zambia to start basic to translational research August